Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: McNeil Products Limited, Foundation Park, Roxborough Way, Maidenhead, Berkshire SL6 3UG, United Kingdom
Children aged 3 months to 12 years: Mild to moderate pain, post-immunisation pyrexia, rheumatic or muscular pain, headache, reduction of fever, sore throat, teething pain, toothache, minor aches and pains, symptoms of cold and influenza.
To be taken orally. For short term use only.
Not recommended for children weighing less than 5 kg.
For pain and fever – 20mg/kg/day in divided doses.
Infants 3-6 months: 2.5 ml three times a day. Do not use for more than 24 hours.
Infants 6-12 months: 2.5 ml three times a day.
Children 1-2 years: 2.5 ml three to four times a day.
Children 3-7 years: 5 ml three to four times a day.
Children 8-12 years: 10 ml three to four times a day.
Doses should be taken every 6–8 hours when required, and at least 4 hours should be left between doses.
2.5 ml (50 mg) followed by one further dose of 2.5 ml (50mg) six hours later if necessary. No more than 2 doses in 24 hours. If fever is not reduced, consult a doctor.
Do not give to children under 3 months of age.
If the child’s symptoms worsen or if the symptoms persist for more than 24 hours, consult a doctor.
If symptoms worsen or if the symptoms persist for more than 3 days, consult a doctor.
In children, ingestion of more than 400mg/kg may cause symptoms. In adults the dose response effect is less clear-cut. The half-life in overdose is 1.5–3 hours.
Most patients who have ingested clinically important amounts of NSAIDs will develop no more than nausea, vomiting, epigastric pain, or more rarely diarrhoea. Tinnitus, headache and gastrointestinal bleeding are also possible. In more serious poisoning, toxicity is seen in the central nervous system, manifesting as drowsiness, occasionally excitation and disorientation or coma. Occasionally patients develop convulsions. In serious poisoning metabolic acidosis may occur and the prothrombin time/INR may be prolonged, probably due to interference with the actions of circulating clotting factors. Acute renal failure and liver damage may occur. Exacerbation of asthma is possible in asthmatics.
Management should be symptomatic and supportive and include the maintenance of a clear airway and monitoring of cardiac and vital signs until stable. Consider oral administration of activated charcoal if the patient presents within 1 hour of ingestion of a potentially toxic amount. If frequent or prolonged, convulsions should be treated with intravenous diazepam or lorazepam. Give bronchodilators for asthma.
36 months.
Do not store above 25°C.
Keep out of reach and sight of children.
Amber glass bottle sealed with a child resistant, tamper evident cap. A syringe with a 2.5 ml and 5 ml measure is supplied with this pack.
Pack sizes: 100ml.
Shake well before use. Return any left over medicine to the Pharmacist.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
